Page 13 - Pharmaceutical
Lupin receives US FDA approval for generic Suprep bowel prep kit
The company has also received US drug regulator's nod for generic Percocet tablet, a pain killer
 "Lupin receives US FDA approval for generic Suprep bowel prep kit")
Zydus Cadila receives US FDA nod for anti-fungal drug fluconazole tablet
It has also received approval for clobetasol propionate spray, used for skin treatment
 "Zydus Cadila receives US FDA nod for anti-fungal drug fluconazole tablet")
Allergan acquires Zeltiq for $2.47 billion
It will enhance Allergan's medical aesthetics portfolio with addition of CoolSculpting system
 "Allergan acquires Zeltiq for $2.47 billion")
Govt plans to establish pharma & medical technology zone at Bengaluru
The move is aimed at reducing the manufacturing cost of drugs and medical devices
 "Govt plans to establish pharma & medical technology zone at Bengaluru")
Study shows antibiotics can stimulate growth in bacteria
UK scientists found that E.coli bacteria increased antibiotic resistance with each treatment
 "Study shows antibiotics can stimulate growth in bacteria")
Daiichi Sankyo shuts down Indian R&D unit
The unit mainly conducted drug discovery research targeting infectious diseases & inflammation
 "Daiichi Sankyo shuts down Indian R&D unit")
Takeda buys Ariad Pharmaceuticals for $ 5.2 billion
Acquisition significantly enhances Takeda's global oncology portfolio
 "Takeda buys Ariad Pharmaceuticals for $ 5.2 billion")
Lupin launches pain killer drug morphine sulfate tablet in US
Tablet is a generic version of MS Contin ER, which had annual US sales of $ 282.9 mn
 "Lupin launches pain killer drug morphine sulfate tablet in US")
Amgen and Immatics to collaborate for cancer drug research
Immatics to receive $ 30 mn upfront & potentially over $ 1 bn in milestone payments & royalties
 "Amgen and Immatics to collaborate for cancer drug research")
Ajanta Pharma receives US FDA approval for antidepressant drug duloxetine
The approved product is a generic version of Eli Lilly & Co's Cymbalta capsule
 "Ajanta Pharma receives US FDA approval for antidepressant drug duloxetine")
Granules India receives 11 observations from Portuguese drug regulator
Infarmed, Portugal, issued these observations for Granules India's Gagillapur facility
 "Granules India receives 11 observations from Portuguese drug regulator")
Aurobindo acquires Portugal's Generis Farmaceutica for € 135 mn
The deal will help Aurobindo to establish itself as one of the leading generics players in Europe
 "Aurobindo acquires Portugal's Generis Farmaceutica for € 135 mn")
US District Court rules in favour of Amgen in Repatha patents cases
The court has prohibited Sanofi & Regeneron from infringing two patents that Amgen holds for Repatha
Natco receives US FDA approval for cancer drug bendamustine
The approved product is generic version of Treanda, which has annual sales of about $ 133 mn in US
 "Natco receives US FDA approval for cancer drug bendamustine")
Stent prices likely to be aligned with CGHS rates
Stent makers have been at loggerheads over differential pricing of drug-eluting stents
 "Stent prices likely to be aligned with CGHS rates")
FIPB approves Sweden-based Recipharm's Kemwell acquisition
In April 2016, Recipharm agreed to buy Kemwell's pharma contract development and manufacturing biz
 "FIPB approves Sweden-based Recipharm's Kemwell acquisition")
Natco launches hepatitis C drug Velpanat in Nepal
Velpanat, a sofosbuvir-velpatasvir fixed dose combination, is generic version of Gilead's Epclusa
Zydus Healthcare buys six brands from MSD
Acquired brands belong to men's health, women's health, cardiovascular & wound management segments
 "Zydus Healthcare buys six brands from MSD")
The year that was 2016: A mixed bag for Indian pharma
Wockhardt has been the worst-hit with three plants being banned from exporting to the US
 "The year that was 2016: A mixed bag for Indian pharma")
Glenmark to enhance R&D activity and focus on specialty products for growth
The company is targeting 30 percent of total revenues from specialty and innovation segments over the next decade
 "Glenmark to enhance R&D activity and focus on specialty products for growth")